2nd Quarter - Report

THE NICKLES GROUP, LLC for CSL BEHRING LLC

Period 2nd Quarter 2020 Filed Jul 20, 2020 Signed by Mary Beth Savary Taylor

Official filing
Firm
THE NICKLES GROUP, LLC
Client
CSL BEHRING LLC
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Homeland Security HOM

Monitored issues involving plasma donors from border countries.

Foreign entity interest: CSL Limited, identified on Registration (LD-1), has an interest in activities of its U.S. subsidiary CSL Behring LLC on all issues.

LobbyistCovered position, as disclosed
DONALD KENT New U.S. Sen Ron Johnson, Chief of Staff; DHS Secretary Michael Chertoff, Asst Sec; DHS Secretary Tom Ridge, Deputy Asst Sec; U.S. Senate Budget Committee, Policy Adv; Office of the Asst. Maj. Leader Nickles Policy Adv.;U.S. Senator Don Nickles,Leg Asst

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; Homeland Security, Dept of (DHS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Health Issues HCR

Monitored issues related to prescription drug pricing. Monitored S. 1895, Lower Health Care Costs Act of 2019, as it relates to pricing transparency and drug pricing. Issues involving promoting plasma donation and convalescent plasma donation.

Foreign entity interest: CSL Limited, identified on Registration (LD-1), has an interest in activities of its U.S. subsidiary CSL Behring LLC on all issues.

LobbyistCovered position, as disclosed
STACEY HUGHES —
EMILY PORTER —
MARY BETH SAVARY TAYLOR —

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Homeland Security, Dept of (DHS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1895 (116th)

Medicare/Medicaid MMM

Issues related to home infusion and DME self-administered therapies. Issues regarding coverage and reimbursement of biologics and plasma therapies. Issues pertaining to drugs listed on the Self-Administered Drug list. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. S. 3457 / H.R. 6218, Preserving Patient Access to Home Infusion Act, as it relates to access to drugs listed on the self-administered drug list. Monitored issues related to drug pricing. Issues related to the corona virus.

Foreign entity interest: CSL Limited, identified on Registration (LD-1), has an interest in activities of its U.S. subsidiary CSL Behring LLC on all issues.

LobbyistCovered position, as disclosed
STACEY HUGHES —
EMILY PORTER —
MARY BETH SAVARY TAYLOR —

Contacted: Health & Human Services, Dept of (HHS); SENATE; Homeland Security, Dept of (DHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 2905 (116th), S. 3457 (116th), S. 2543 (116th), H.R. 6218 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.